Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data

BACKGROUND: Esophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data from the BEST3 trial has shown that an offer of Cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Swart, Nicholas, Maroni, Roberta, Muldrew, Beth, Sasieni, Peter, Fitzgerald, Rebecca C., Morris, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225801/
https://www.ncbi.nlm.nih.gov/pubmed/34195582
http://dx.doi.org/10.1016/j.eclinm.2021.100969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225801/
https://www.ncbi.nlm.nih.gov/pubmed/34195582
http://dx.doi.org/10.1016/j.eclinm.2021.100969

Ejemplares similares